MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
about
MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@en
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@nl
type
label
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@en
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@nl
prefLabel
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@en
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@nl
P2093
P2860
P356
P1476
MT4-MMP and EGFR expression le ...... to chemotherapy and erlotinib.
@en
P2093
Agnès Noël
Alice Truong
Cassandre Yip
Emilie Feyereisen
Guy Jerusalem
Hélène Schroeder
Joan Somja
Joëlle Collignon
Mehdi Lienard
Nor Eddine Sounni
P2860
P2888
P304
P356
10.1038/BJC.2017.23
P407
P577
2017-02-14T00:00:00Z